Angiosarcoma and Breast Cancer Recurrence Eight Years Following Mammosite Therapy
نویسندگان
چکیده
منابع مشابه
Evaluation of Local Recurrence of Breast Cancer after Mastectomy and Breast Preservation Therapy
Abstract Introduction: Breast cancer is the most common cancer among women. Even though mastectomy is known as a highly effective method to treat breast cancer, the percentage of patients with local recurrence is still high. Objective: To determine the incidence of local recurrence after mastectomy and breast preservation surgery. Materials and Methods: Patients with breast cancer that under...
متن کاملPaclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma.
Among angiosarcomas, radiation-induced breast sarcomas (RIBS) represent a well-known entity generally characterized by a poor outcome, especially in patients with advanced disease. Despite the unfavorable prognosis, some chemotherapeutic agents have been used to treat these malignancies, occasionally with success. Treatments with demonstrated activity against sarcomas include ifosfamide-based r...
متن کاملSmoking and Breast Cancer Recurrence after Breast Conservation Therapy
Background. Prior studies have shown earlier recurrence and decreased survival in patients with head and neck cancer who smoked while undergoing radiation therapy. The purpose of the current study was to determine whether smoking status at the time of partial mastectomy and radiation therapy for breast cancer affected recurrence or survival. Method. A single institution retrospective chart revi...
متن کاملReview: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer.
MAIN RESULTS 194 RCTs (n=144 939) were included and comprise about 91% of all women randomised in such trials before 2000. Standard polychemotherapy, including an anthracycline for 4–6 months (eg, fluorouracil, cyclophosphamide, and either doxorubicin [adriamycin] or epirubicin [FAC or FEC]) reduced annual breast cancer mortality rates by 38% in women ,50 years and by 20% in women 50–69 years (...
متن کاملResidual risk of breast cancer recurrence 5 years after adjuvant therapy.
There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and prognostic factors of 2838 patients with stage I-III breast cancer who were treated with AST between January 1, 1985, and November 1, 2001, and remained disease free for 5 years. Res...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Breast Journal
سال: 2014
ISSN: 1075-122X
DOI: 10.1111/tbj.12337